Koyfin Home > Directory > Health Care > Gilead Sciences Inc > Cash Flow from Operations

Gilead Sciences Inc Cash Flow from Operations Chart (GILD)

Gilead Sciences Inc annual/quarterly Cash Flow from Operations from 2010 to 2020. Cash flow from operating activities (CFO) is an accounting item that indicates the amount of money a company brings in from ongoing, regular business activities, such as manufacturing and selling goods or providing a service. Cash flow from operating activities does not include long-term capital or investment costs.
  • Gilead Sciences Inc Cash Flow from Operations for the quarter ending September 09, 2020 was $2,250m a -14.67% decrease of -330m year over year
  • Gilead Sciences Inc Cash Flow from Operations for the last 12 months ending September 09, 2020 was $8,832m a -3.53% decrease of -312m year over year
  • Gilead Sciences Inc Annual Cash Flow from Operations for 2019 was $9,144m a 8.14% increase of 744m from 2018
  • Gilead Sciences Inc Annual Cash Flow from Operations for 2018 was $8,400m a -41.64% decrease of -3,498m from 2017
  • Gilead Sciences Inc Annual Cash Flow from Operations for 2017 was $11,898m a -43.28% decrease of -5,149m from 2016
Other Cash Flow Metrics:
  • Gilead Sciences Inc Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $1,592m a -123.19% decrease of -1,962m year over year
  • Gilead Sciences Inc Total Revenue for the quarter ending December 12, 2018 was $5,795m a 12.20% increase of 707m year over year
View Chart On Koyfin

Quarterly GILD Cash Flow from Operations Data

09/2020$2,250m
06/2020$2,566m
03/2020$1,436m
12/2019$2,580m
09/2019$2,645m
06/2019$2,342m
03/2019$1,577m
12/2018$2,345m
09/2018$2,212m
06/2018$1,573m

Annual GILD Cash Flow from Operations Data

2019$9,144m
2018$8,400m
2017$11,898m
2016$17,047m
2015$21,250m
2014$12,818m
2013$3,105m
2012$3,195m
2011$3,639m
2010$2,834m